Nasonex Aquosum (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex Aquosum, is a corticosteroid presented as a nasal spray for intranasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis and nasal polyps in adults and adolescents.

GNH USA supplies Nasonex Aquosum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages.

Allergic rhinitis: alleviates nasal congestion, sneezing, itching and rhinorrhea. Nasal polyps: reduces polyp size and improves nasal airflow. Seasonal allergic rhinitis: controls symptoms during pollen exposure periods.

Intranasal mometasone furoate may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Sore throat - Cough - Altered taste perception

Serious or Rare Side Effects: - Adrenal suppression - Glaucoma or cataract development - Severe allergic reaction (anaphylaxis) - Fungal sinusitis - Nasal septal perforation - Systemic immunosuppression leading to infection

When prescribing Nasonex Aquosum, clinicians should consider several precautionary measures.

Assess for active infections: avoid use in untreated bacterial, fungal or viral nasal infections. Monitor for ocular effects: prolonged use may increase risk of glaucoma or cataract. Evaluate systemic corticosteroid exposure: limit concurrent systemic steroids to reduce adrenal suppression risk. Use the lowest effective dose: aim to control symptoms with minimal exposure. Store at room temperature: keep in original container, protect from moisture and heat.

Mometasone furoate can interact with other medicines, altering its safety or efficacy.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local exposure. - Live vaccines: intranasal steroids may reduce immune response.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase local irritation. - Nasal decongestant sprays: concurrent use can increase nasal mucosa dryness. - Antifungal nasal agents: may affect local flora.